<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Glutathione Peroxidase 6</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GPX6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Glutathione Peroxidase 6</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q33.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[257202](https://www.ncbi.nlm.nih.gov/gene/257202)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614484</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000163235</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P22352](https://www.uniprot.org/uniprot/P22352)</td></tr>
<tr><td><strong>Cofactor</strong></td><td>Selenocysteine (Sec)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis</td></tr>
</table>
</div>
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Glutathione Peroxidase 6</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>GPX6</td></tr>
<tr><td><strong>Full Name</strong></td><td>Glutathione Peroxidase 6</td></tr>
<tr><td><strong>Chromosome</strong></td><td>5q33.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[257202](https://www.ncbi.nlm.nih.gov/gene/257202)</td></tr>
<tr><td><strong>OMIM</strong></td><td>614484</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000163235</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P22352](https://www.uniprot.org/uniprot/P22352)</td></tr>
<tr><td><strong>Cofactor</strong></td><td>Selenocysteine (Sec)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis</td></tr>
</table>
</div>
GPX6 (Glutathione Peroxidase 6) is a member of the glutathione peroxidase family of selenoproteins that catalyzes the reduction of hydrogen peroxide (H₂O₂) and organic hydroperoxides to water and corresponding alcohols, using glutathione (GSH) as an electron donor. Located on chromosome 5q33.1, GPX6 is unique among the glutathione peroxidases due to its distinctive tissue expression pattern, with particularly high expression in the olfactory epithelium and specific brain regions. This enzyme plays a critical role in protecting neurons and glial cells from oxidative stress—a key pathological feature in neurodegenerative diseases including Parkinson's disease (PD), Alzheimer's disease (AD), and multiple sclerosis (MS).[@leist2004]
The glutathione peroxidase family comprises several isoforms (GPX1-8) that share a common catalytic mechanism but differ in cellular localization, tissue distribution, and substrate specificity. GPX6, along with GPX3 and GPX5, represents a extracellular or secreted form, though it also has significant intracellular expression in specific tissues. The presence of selenocysteine (Sec) at the active site—the 21st amino acid encoded by a UGA codon in a specific context—makes GPX6 a selenoprotein, dependent on selenium for its function. This selenium dependence has important implications for nutrition, disease susceptibility, and therapeutic approaches.
Oxidative stress is a fundamental pathological mechanism in neurodegenerative diseases, arising from the accumulation of reactive oxygen species (ROS) that overwhelm cellular antioxidant defenses. Dopaminergic neurons in the substantia nigra are particularly vulnerable due to their high metabolic demand, iron content, and the oxidative metabolism of dopamine.[@ischiropoulos2009] In Alzheimer's disease, oxidative stress contributes to amyloid toxicity, tau phosphorylation, and neuronal death. GPX6, as a key antioxidant enzyme, helps neutralize ROS and maintain cellular redox balance.[@schweizer2017] Understanding GPX6's functions provides insight into disease mechanisms and identifies potential therapeutic targets for enhancing antioxidant defense.
The GPX6 gene is located on chromosome 5q33.1 and encodes a protein of 197 amino acids with a molecular weight of approximately 22 kDa. The gene structure follows the pattern of selenoprotein genes, containing a Sec insertion sequence (SECIS) element in the 3' untranslated region that is required for recoding the UGA codon from a stop codon to selenocysteine incorporation. This recoding requires specific RNA-binding proteins and a unique translation mechanism that distinguishes GPX6 from standard proteins.
The protein structure of GPX6 consists of a single polypeptide chain folded into a characteristic thioredoxin-like fold common to all glutathione peroxidases. The active site contains the motif Sec-Try-Gly (Sec-UNC- Gly), where selenocysteine performs the nucleophilic attack on peroxide substrates. The selenium atom in selenocysteine provides extraordinary catalytic efficiency compared to cysteine-containing analogues, making GPX6 a highly efficient peroxide-scavenging enzyme. The structural fold creates a shallow active site pocket that accommodates various peroxide substrates.
GPX6 is expressed as a secreted glycoprotein in many tissues, consistent with its classification as a extracellular glutathione peroxidase. The signal peptide at the N-terminus directs the protein to the secretory pathway, and N-linked glycosylation occurs in the Golgi apparatus. However, significant intracellular expression has also been documented, particularly in olfactory epithelium and specific brain regions. The balance between secreted and intracellular forms may vary with tissue type and physiological context.
Expression of GPX6 is regulated at multiple levels. Selenium availability is the primary determinant of GPX6 expression—selenium deficiency reduces GPX6 levels, while selenium supplementation can increase them. Transcriptional regulation also contributes, with some evidence for regulation by oxidative stress, hormones, and developmental factors. The promoter region contains response elements that may mediate these effects.
GPX6 catalyzes the reduction of peroxides using glutathione as the electron donor. The catalytic cycle begins with the selenolate form of the active site selenocysteine (Se⁻) attacking the peroxide substrate, forming a selenenyl-sulfide intermediate (Se-OH) and releasing water or an alcohol. This intermediate then reacts with a molecule of reduced glutathione (GSH), forming a selenenyl-glutathione intermediate (Se-SG) and releasing the reduced product. A second GSH molecule then reduces this intermediate, regenerating the active selenolate and producing oxidized glutathione (GSSG).
The catalytic efficiency of GPX6, like other glutathione peroxidases, is remarkable—each enzyme molecule can catalyze the turnover of millions of peroxide molecules per minute. This high turnover rate depends on the unique chemistry of selenocysteine, which has a lower pKa (~5.2) than cysteine (~8.3), allowing it to exist as the reactive selenolate form at physiological pH. The enzyme also displays ping-pong kinetics, with substrate and product binding occurring in a sequential manner.
GPX6 accepts various peroxide substrates including hydrogen peroxide, organic hydroperoxides (such as lipid peroxides), and peroxynitrite to some extent. This substrate versatility allows GPX6 to neutralize multiple forms of reactive oxygen and nitrogen species. The preference for specific substrates may vary with cellular context and the local peroxide environment.
Glutathione, the physiological electron donor for GPX6, must be maintained in its reduced form (GSH) for catalytic activity. Cellular GSH levels therefore influence GPX6 function, and the enzyme works in concert with other components of the glutathione system including glutathione reductase, which recycles GSSG back to GSH. The overall system creates a coordinated antioxidant defense network.
GPX6 is a critical component of the cellular antioxidant defense system, working alongside other antioxidant enzymes including superoxide dismutase (SOD), catalase, and peroxiredoxins. While these enzymes all contribute to neutralizing reactive oxygen species, they have distinct specificities and cellular distributions that together provide comprehensive protection.
Superoxide dismutases (SOD1, SOD2, SOD3) convert superoxide radical (O₂⁻) to hydrogen peroxide, which GPX6 can then reduce to water. Catalase also reduces hydrogen peroxide but is primarily localized to peroxisomes. Peroxiredoxins reduce peroxides using a different mechanism involving cysteine residues. The分工 between these enzymes ensures that various forms of ROS are handled appropriately.
In the brain, GPX6's role in antioxidant defense is particularly important due to several factors. The brain has high metabolic demand and oxygen consumption but relatively lower antioxidant capacity compared to some other organs. Neuronal activity generates ROS, and the high iron content of certain brain regions promotes oxidative reactions. The blood-brain barrier limits the import of some antioxidant molecules, making endogenous enzymes like GPX6 especially important.
Glutathione levels in the brain are lower than in many other organs, potentially limiting the substrate availability for GPX6. However, the catalytic efficiency of selenoprotein peroxidases allows them to function effectively even when glutathione is limiting to some extent. The interplay between GPX6 and other components of the glutathione system determines the overall antioxidant capacity.
GPX6 exhibits a distinctive expression pattern in the central nervous system, with high expression in the olfactory epithelium and specific brain regions. In the brain, GPX6 is expressed in various neuronal populations and glial cells, with particular enrichment in areas associated with smell and certain cognitive functions.
In neurons, GPX6 expression provides protection against oxidative stress generated during normal neuronal activity and in response to pathological challenges. The enzyme is expressed in various brain regions including the olfactory bulb, hippocampus, cerebral cortex, and cerebellum. This broad distribution suggests important functions throughout the CNS.
Glial cells including astrocytes and microglia also express GPX6. Astrocytes are important for maintaining extracellular antioxidant capacity, and their secretion of GPX6 contributes to the extracellular antioxidant environment. Microglial GPX6 may help manage oxidative stress generated during immune activation.
The olfactory epithelium has particularly high GPX6 expression, and this may relate to the unique oxidative challenges in this tissue. The olfactory epithelium is directly exposed to environmental oxidants and xenobiotics, requiring robust antioxidant defenses. GPX6's high expression there may also reflect a role in olfactory function.
GPX6 has been implicated in Parkinson's disease pathogenesis through its antioxidant functions and the particular vulnerability of dopaminergic neurons to oxidative stress. The substantia nigra pars compacta, the brain region most affected in PD, has high levels of oxidative stress due to dopamine metabolism, iron accumulation, and mitochondrial dysfunction.
Dopamine oxidation produces reactive oxygen species, including hydrogen peroxide and quinones. The substantia nigra also has high iron content, which can catalyze ROS formation through Fenton chemistry. Mitochondrial complex I deficiency in PD leads to increased electron leak and superoxide production. This combination of sources creates exceptionally high oxidative stress in dopaminergic neurons.
GPX6 helps neutralize some of this oxidative stress through its peroxidase activity. By reducing hydrogen peroxide and lipid peroxides, GPX6 protects dopaminergic neurons from oxidative damage. Studies have shown altered GPX6 expression in PD models and post-mortem tissue, though the direction of change varies between studies. Some report decreased GPX6, suggesting insufficient antioxidant defense, while others report increased GPX6, potentially representing a compensatory upregulation.
Genetic association studies have investigated GPX6 variants and PD risk. Some polymorphisms in the GPX6 gene have been associated with altered PD risk, though results have not been consistent across all populations. These genetic findings support the biological relevance of GPX6 in PD, though the functional significance of specific variants requires further study.
Therapeutic strategies targeting GPX6 in PD include selenium supplementation, which could enhance GPX6 expression and activity. However, the relationship between selenium and PD is complex—while selenium is essential for GPX6 function, excessive selenium may also be problematic. The therapeutic window and optimal dosing require careful consideration.
In Alzheimer's disease, oxidative stress is an early and prominent feature that contributes to amyloid toxicity, tau pathology, and neuronal death. GPX6 may play a protective role by neutralizing peroxides generated in the AD brain.
Amyloid-beta peptides, particularly in oligomeric forms, can induce oxidative stress in neurons and glia. Aβ interacts with cell membranes and receptors, triggering NADPH oxidase activation and ROS production. The enzyme also promotes lipid peroxidation and protein oxidation. GPX6 can reduce some of these peroxides, potentially limiting Aβ-induced oxidative damage.
Tau pathology also involves oxidative stress. Hyperphosphorylated tau aggregates may be resistant to normal degradation and can induce cellular stress. Oxidative modifications of tau itself may promote its aggregation. GPX6's antioxidant functions could potentially limit these processes.
Gene expression studies have found altered GPX6 levels in AD brain, with some studies reporting decreased expression in affected regions. This decrease could reflect neuronal loss, impaired antioxidant response, or consumption of GPX6 in neutralizing oxidative stress. The precise changes likely depend on disease stage and individual variability.
In multiple sclerosis, oxidative stress contributes to demyelination and neuronal injury. GPX6 and other antioxidant enzymes help protect myelin-producing oligodendrocytes and neurons from oxidative damage.
Demyelination in MS involves attacks on myelin by immune cells, including macrophages and microglia that produce ROS. The inflammatory environment in MS lesions creates significant oxidative stress. Oligodendrocytes, which produce myelin, are particularly vulnerable to oxidative damage due to their high metabolic activity and limited antioxidant capacity.
GPX6 expressed in the CNS may help protect oligodendrocytes and neurons from inflammatory oxidative stress. The enzyme's ability to reduce lipid peroxides is particularly relevant, as myelin is rich in lipids that are susceptible to peroxidation. Preventing lipid peroxidation helps maintain myelin integrity.
Studies in MS models and patient samples have investigated GPX6 and other antioxidant enzymes. Some studies report decreased GPX6 activity in MS lesions, potentially contributing to demyelination. Therapeutic approaches to enhance antioxidant defenses, including selenium and other antioxidants, have been explored in MS.
The glutathione peroxidase family includes several selenoproteins (GPX1, GPX2, GPX3, GPX4, GPX6) and one cysteine-containing member (GPX5). Each isoform has distinct tissue distribution and functional characteristics, though all share the basic catalytic mechanism.
GPX1 is the most abundant and widely expressed isoform, present in virtually all tissues with particularly high levels in liver and kidney. It primarily reduces hydrogen peroxide and is an important cytoplasmic antioxidant. GPX2 is expressed in gastrointestinal tract and provides protection against oxidative damage from gut contents. GPX3 is primarily a plasma selenoprotein secreted from kidneys, contributing to extracellular antioxidant defense. GPX4 (PHGPX) is unique in its ability to reduce phospholipid hydroperoxides within membranes, making it important for preventing ferroptosis, a form of regulated cell death.
GPX6 shares some functional features with GPX3 as a secreted selenoprotein but has distinct expression patterns, particularly in the olfactory system and brain. The relationship between these isoforms in providing antioxidant protection is an area of ongoing research.
The transcriptional regulation of GPX isoforms differs, allowing tissue-specific and context-dependent expression. While selenium availability affects all selenoproteins, individual isoforms can be differentially regulated by oxidative stress, inflammation, and other factors. This regulation creates flexibility in the antioxidant response.
GPX6 represents a potential therapeutic target for neurodegenerative diseases through several mechanisms. Enhancing GPX6 expression or activity could improve antioxidant defense and protect neurons from oxidative damage.
Selenium supplementation: As a selenoprotein, GPX6 depends on selenium for its function. Selenium supplementation can increase GPX6 expression, potentially enhancing antioxidant capacity. However, selenium has a narrow therapeutic window—deficiency impairs function while excess can be toxic. Careful dosing is required.
Small molecule activators: Compounds that directly enhance GPX6 activity could provide benefits without requiring selenium. However, such compounds have not been extensively developed for this specific target.
Gene therapy: Delivering GPX6 to affected brain regions using viral vectors could provide localized antioxidant enhancement. This approach has been explored in preclinical models but faces challenges related to delivery and expression levels.
Combination approaches: Enhancing GPX6 as part of a broader antioxidant strategy may be most effective. Combining GPX6 enhancement with other antioxidant enzymes, glutathione precursors, or mitochondrial protectants could provide synergistic benefits.
Biomarker applications for GPX6 are also being explored. GPX6 levels in cerebrospinal fluid or blood might serve as markers of disease state or therapeutic response. As a selenium-dependent enzyme, GPX6 could also provide information about selenium status.
GPX6 is one of approximately 25 selenoproteins in humans, proteins that incorporate selenocysteine at their active sites. Selenium is an essential trace element obtained from the diet, primarily from Brazil nuts, seafood, and organ meats. The selenium status of an individual profoundly influences the expression and activity of GPX6 and other selenoproteins.
Selenium is absorbed in the gut and transported to the liver, where it is incorporated into selenoprotein P for distribution to other tissues. The selenoproteome includes various antioxidant enzymes (GPXs, Selenoprotein P, Selenoprotein K, etc.), thioredoxin reductases, and other proteins with diverse functions. The coordinated regulation of selenoprotein expression ensures appropriate selenium distribution.
Selenium deficiency is associated with increased oxidative stress and has been linked to various diseases, including neurodegenerative conditions. Conversely, selenium excess can be toxic, causing selenosis with symptoms including hair loss, nail changes, and neurological abnormalities. The balance is critical.
In the brain, selenium uptake is regulated by the blood-brain barrier, and brain selenium levels are relatively well-maintained even when systemic selenium is limited. However, in neurodegeneration, altered selenium homeostasis has been observed, and therapeutic supplementation has been explored.